Margins in Focus: Can Waaree Arrest Q1's Profitability Slide?
Q2 will test whether the solar manufacturer can stabilize operating leverage after Q1's sharp EBITDA margin contraction. Street is divided; execution on capacity ramp and module pricing will be decisive.
What to Expect: The Margin Question
Waaree reported Q1 FY27 revenue growth of 79% YoY to ₹7,932 Cr, but profit growth lagged at 15% as EBITDA margin collapsed from 22.53% to 18.15% and PAT margin fell from 16.81% to 11.01%. Management blamed input cost inflation and global metal index pressure; a ₹349 Cr duty refund buoyed earnings. Q2 will reveal whether this was transient or structural. The Street debate hinges on two things: (1) can module realization prices hold amid capacity churn? (2) will the newly scaled inverter and transformer lines offset raw material headwinds?
~₹7,500–8,200 Cr
Sequential growth from Q1's ₹7,932 Cr; capacity utilization and order fulfilment pace
18–20%
Below FY26 avg (22–23%) but improvement on Q1's 18.15%; commodity stabilization is the wildcard
11–13%
Depends on exceptional items; no ₹349 Cr duty refund baked in for Q2
60–70%
US facility ramp, 1.1 GW inverter production, 4 GW total inverter capacity by end-Q2
A strong print would show EBITDA margin recovery toward 20% or better, paired with sustained revenue growth sequentially and modest guidance for module realization hold. A weak print would be EBITDA margin below 18%, further margin guidance cuts, or capacity ramp delays offsetting revenue growth.
On Track?
Waaree's FY27 full-year EBITDA guidance is ₹7,000–7,700 Cr. At that level, implied quarterly average is ₹1,750–1,925 Cr EBITDA. Q1 delivered ₹1,441 Cr (18.15% margin on ₹7,932 Cr revenue). Q2 needs to stay above ₹1,750 Cr to remain on track; anything below signals a guidance miss. The company has warned of margin pressure from raw material inflation, but capacity scaling (inverters, transformers, the Indosolar backward integration) should drive margin recovery in H2. Execution risk is high; so is upside if input costs stabilize.
What the Street Says
Since Last Quarter: Expansion, Orders, and Consolidation
1 · Inverter Capacity Surge
Waaree Power (subsidiary) commenced 1.1 GW solar inverter production on Sep 30, scaling total inverter capacity to 4.15 GW. This feeds FY27 guidance for 4 GW nameplate inverter production. Margin accretion depends on utilization and product mix.
2 · 2 GW Module Order
Major domestic solar developer awarded 2 GW module supply order on Sep 21. One-time supply, no multi-year contract detail disclosed. Tests pricing power and fulfillment capacity in a competitive market.
3 · Indosolar Merger Approval
Board approved draft Scheme of Amalgamation on Sep 24 (subject to NCLT/shareholder approval). Backward integration play—adds cell and module capacity, aims to simplify group structure. Post-integration synergies key to FY28 margin trajectory.
4 · Promoter Stake Build
C.T. Doshi Family Trust (promoter entity) indirectly acquired 18.34% stake in WSFPL in early Sep. Indirect ownership shuffle; no direct voting impact disclosed, but signals long-term confidence in execution.
5 · Manufacturing Consolidation
Relocation of plants from Tumb and Nandigram to Chikli, Gujarat (Aug 29). Operational efficiency play; capex and restructuring costs may weigh on margins in Q2–Q3 but should unlock synergies by H2.
Three Things to Watch on Result Day
1 · EBITDA Margin Trend
Is Q2 EBITDA margin ≥ 20%? Below 18% is a fresh miss. Management guidance on FY27 full-year margin band will reset Street expectations. Any material revision downward triggers target cuts across the board.
2 · Module Realization Pricing
Management must clarify average selling prices (ASP) for modules, inverters, and transformers. Pricing under pressure? Or stabilizing? This is the core driver of whether Q1's margin miss was cyclical or structural.
3 · US & Inverter Ramp Progress
Capacity utilization at US facility and inverter production ramp. Targets from Aug guidance for ₹37M US capex and 4 GW inverter output by year-end: on track or slipping? Ramp delays amplify margin pressure.
Waaree reports a quarter where structural capacity growth will be tested against near-term cost inflation and pricing pressure. Q1 was a warning: 79% revenue growth but 15% profit growth is not sustainable, and one-time refunds were a crutch. Q2 must show that the margin miss was cyclical—commodity inflation and mix—not a permanent feature of the enlarged capacity base. The Indosolar deal and inverter ramp are growth catalysts for H2, but investors will be focused on the next 90 days: can margins stabilize, and is full-year guidance credible? Street consensus is +38% upside, but that hinges entirely on execution.
Waaree Q2: Consolidated PAT falls 14% YoY, margins compress despite tariff refund
PAT -14.19% YoY · revenue +23.94% · margins compressing · miss vs street
₹7,517.74 Cr
+23.94% YoY
₹753.64 Cr
-14.19% YoY
9.83%
-4.3pp YoY
₹24.98
Waaree Energies' consolidated PAT for Q2 FY27 (quarter ended September 30, 2026) fell 14.2% YoY to ₹753.6 Cr from ₹878.2 Cr a year ago, and was down 15.5% sequentially from ₹891.9 Cr in Q1 FY27 — even as consolidated revenue from operations grew 23.9% YoY to ₹7,517.7 Cr (down 5.2% QoQ). The headline growth is flattered by a one-off: following a US Supreme Court ruling that reciprocal IEEPA tariffs on exporters were unlawful, the Group recognised ₹360.4 Cr as "other operating revenue" plus a ₹25.1 Cr reduction in cost of materials/inventory (Note 6). Stripped of this ₹385.5 Cr pre-tax tailwind, adjusted revenue growth was 18.0% YoY and adjusted PAT fell roughly 46% YoY to an estimated ₹471 Cr — a materially weaker underlying print than the reported numbers suggest. Our pre-result preview flagged a PAT margin range of 11-13% and EBITDA margin of 18-20%; actual NPM came in at 10.0% reported (6.6% adjusted), below that band, while revenue (within ₹7,500-8,200 Cr) and reported EBITDA margin (~19.7%) were met only on an unadjusted basis.
Q2 FY-2027 vs prior quarters
Consolidated NPM compressed to 10.0% (6.6% adjusted) from 14.5% a year ago and 11.2% last quarter, and EBITDA margin fell to roughly 19.7% (15.3% adjusted) from about 25.8% in Q2 FY26 — continuing, not arresting, the slide our preview ("Margins in Focus") flagged after Q1's contraction. By segment, Solar PV Modules (87% of revenue) grew 22.4% YoY but fell 11.2% QoQ to ₹6,571.0 Cr; EPC contract revenue dropped 41.4% YoY to ₹447.2 Cr; and the newer Transmission & Distribution segment surged to ₹606.1 Cr from ₹112.8 Cr a year ago, partly offsetting the EPC decline. Finance costs rose to ₹105.3 Cr from ₹96.1 Cr YoY as capex scaled (capital work-in-progress up to ₹7,578.3 Cr from ₹3,476.2 Cr at FY26-end) ahead of revenue.
The stock went into the print at ₹2,275, down 8.3% over the past month of trading.
What the summary numbers don't show
Segment mix shifted — Transmission & Distribution revenue jumped to ₹606 Cr from ₹113 Cr YoY (+437%) while EPC revenue fell 41% YoY to ₹447 Cr; core Solar PV Module revenue (87% of sales) grew 22% YoY but fell 11% QoQ to ₹6,571 Cr.
FY27 operating EBITDA ₹7,000-7,700 Cr reaffirmed (maintained). Cell capacity 5.4→15.4 GW by year-end, module ramp to 70-75% utilization Q3-Q4. Retail targeting ₹9,000-10,000 Cr FY27.
— This quarter: missed
The standalone (parent-only) numbers diverge sharply from the consolidated picture — standalone revenue was effectively flat YoY at ₹4,577.6 Cr (-0.1%, or -6.3% stripping its own ₹282.3 Cr tariff-refund credit) and standalone PAT fell 42.1% YoY to ₹670.9 Cr, versus the group's milder 14.2% decline — meaning nearly all of this quarter's consolidated growth is coming from subsidiaries, not the parent. Management's FY27 operating EBITDA guidance of ₹7,000-7,700 Cr, reaffirmed last quarter, looks stretched: H1 FY27 adjusted EBITDA of roughly ₹2,707 Cr annualises well below the guided band, leaving H2 to carry a steep ramp as cell capacity scales toward the stated 15.4 GW year-end target and module utilisation moves to the guided 70-75% in Q3-Q4 — neither disclosed in this filing to verify progress. No management press-release commentary was provided alongside this filing to compare against the numbers.
W1
H2 FY27 pace vs the reaffirmed ₹7,000-7,700 Cr FY27 EBITDA guidance — H1 run-rate of ~₹2,707 Cr (adjusted) implies H2 needs to deliver roughly ₹4,300-5,000 Cr to hit the band.
W2
Cell capacity progress from 5.4 GW toward management's 15.4 GW year-end target and module utilisation reaching the guided 70-75% in Q3-Q4 — neither disclosed in this filing.
W3
Resolution of the US CBP AD/CVD review flagged in Note 5 after the ₹294.78 Cr FY26 provision — the company has sought administrative review on entries CBP flagged this quarter.
Clean, legible statement; all totals tie exactly (PBT-tax=PAT, revenue+other income=total income). Consolidated PAT of ₹753.64 Cr includes ₹34.96 Cr non-controlling interest (owners' share ₹718.68 Cr is the EPS base). No exceptional item this quarter (the ₹294.78 Cr exceptional item sits only in the FY26 full-year column, from the US CBP provision). Revenue from operations and cost of materials this quarter embed a ₹360.40 Cr IEEPA tariff-refund credited as other operating revenue plus a ₹25.13 Cr cost reduction (consol, Note 6; ₹282.30 Cr on standalone) — a one-off tailwind excluded in the adjusted figures below.